Korea Novel Drug Prices 50% Of Similar Countries, But A Window Opens For Reform
This article was originally published in The Pink Sheet Daily
Executive Summary
MNC pharma association in Korea lobbies for delinking generic drugs from new drug pricing in year ahead.